Bio

Kevin has more than 20 years of sales and business development experience in the private equity, pharmaceutical, and health information technology sectors. Prior to joining Riverside Partners in 2022, Kevin spent 14 years at H.I.G. Capital where he led deal origination and capital deployment efforts across H.I.G.’s North American buyout and growth equity funds. His previous experience includes sales and business development roles at Solvay Pharmaceuticals and Zix Corporation (NASDQ:ZIXI). Kevin holds a Bachelor of Science degree from Fordham University.